Patrick Hurban, Ph.D. | January 27, 2016

Genomics throughout the Drug Development Process

Part three
Genomic technologies can be applied in all phases of the drug development process. In the last of a three-part video series, Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions, discusses the impact of genomics in drug development – from early research and development and discovery to clinical development. You’ll also learn why the adoption of genomic technologies is important throughout the project lifecycle.

Related Services:
Genomics enhances Clinical Immuno-oncology Trials

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Read More